NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Guanhao Biotech Co.Ltd (SHE: 300238)
300238 Technical Analysis
2
As on 31st Mar 2025 300238 STOCK Price closed @ 13.94 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 11.26 & Sell for SHORT-TERM with Stoploss of 14.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300238STOCK Price
Open | 13.89 | Change | Price | % |
High | 14.58 | 1 Day | -0.86 | -5.81 |
Low | 13.84 | 1 Week | 0.60 | 4.50 |
Close | 13.94 | 1 Month | 0.88 | 6.74 |
Volume | 38738319 | 1 Year | -0.64 | -4.39 |
52 Week High 15.30 | 52 Week Low 7.81 |
SHE China Most Active Stocks
002195 | 5.54 | 0.00% |
000725 | 4.15 | -1.43% |
000958 | 6.78 | -1.60% |
002131 | 3.60 | -2.44% |
300059 | 22.58 | -1.83% |
000630 | 3.43 | -2.00% |
002639 | 8.54 | -4.26% |
002204 | 6.25 | -9.94% |
000100 | 4.45 | 0.45% |
300230 | 5.60 | -5.56% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300238 Daily Charts |
300238 Intraday Charts |
Whats New @ Bazaartrend |
300238 Free Analysis |
|
300238 Important Levels Intraday
RESISTANCE | 15.37 |
RESISTANCE | 14.91 |
RESISTANCE | 14.63 |
RESISTANCE | 14.34 |
SUPPORT | 13.54 |
SUPPORT | 13.25 |
SUPPORT | 12.97 |
SUPPORT | 12.51 |
300238 Forecast April 2025
4th UP Forecast | 19.26 |
3rd UP Forecast | 17.55 |
2nd UP Forecast | 16.5 |
1st UP Forecast | 15.44 |
1st DOWN Forecast | 12.44 |
2nd DOWN Forecast | 11.38 |
3rd DOWN Forecast | 10.33 |
4th DOWN Forecast | 8.62 |
300238 Weekly Forecast
4th UP Forecast | 15.98 |
3rd UP Forecast | 15.33 |
2nd UP Forecast | 14.92 |
1st UP Forecast | 14.52 |
1st DOWN Forecast | 13.36 |
2nd DOWN Forecast | 12.96 |
3rd DOWN Forecast | 12.55 |
4th DOWN Forecast | 11.90 |
300238 Forecast2025
4th UP Forecast | 30.61 |
3rd UP Forecast | 25.26 |
2nd UP Forecast | 21.96 |
1st UP Forecast | 18.65 |
1st DOWN Forecast | 9.23 |
2nd DOWN Forecast | 5.92 |
3rd DOWN Forecast | 2.62 |
4th DOWN Forecast | -2.73 |
Guanhao Biotech Co.Ltd ( SHE China Symbol : 300238 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300238 Other Details
Segment | EQ | |
Market Capital | 4279617792.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
300238 Address
![]() |
300238 Latest News
300238 Business Profile
Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China. Address: No. 12 Yuyan Road, Guangzhou, China, 510530
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service